Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT01626105
Eligibility Criteria:
Inclusion Criteria:
* Patients with severe or moderately severe hemophilia A (HA) who have since birth been treated with only a single Factor VIII product (i.e., FVIII protein molecules containing only one primary amino acid sequence).
Exclusion Criteria:
* HA patients with severities other than severe or moderately severe.
* Hemophilia B patients.
* HA patients who have been treated with more than one FVIII product.
* HA patients who have been treated with more than one FVIII product.
* HA patients who do not have verifiable infusion histories.
* HA patients who lack documentable inhibitor testing \& infusion histories.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
2 Years
Study:
NCT01626105
Study Brief:
Protocol Section:
NCT01626105